Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Endometrial cancer | R-HSA-2077421 | map05213 | harmol | 101616 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | harmol | 101616 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | ajmaline | 6100671 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | ajmaline | 6100671 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | ajmaline | 6100671 | drug-path |
| Melanogenesis | R-HSA-5662702 | map04916 | ajmaline | 6100671 | drug-path |
| Glioma | Q9NZM4 | map05214 | ajmaline | 6100671 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | ajmaline | 6100671 | drug-path |
| Long-term potentiation | R-HSA-9620244 | map04720 | ajmaline | 6100671 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | ajmaline | 6100671 | drug-path |
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | ajmaline | 6100671 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | iodixanol | 3724 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | iodixanol | 3724 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | iodixanol | 3724 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | iodixanol | 3724 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | iodixanol | 3724 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | iodixanol | 3724 | drug-path |
| Asthma | R-HSA-444620 | map05310 | iodixanol | 3724 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | iodixanol | 3724 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | iodixanol | 3724 | drug-path |